Use of artificial intelligence and big data in transfusion medicine: An exploratory assessment of status in the Eastern Mediterranean and North Africa region.

BACKGROUND AND

OBJECTIVES

Artificial intelligence (AI) and big data are technologies with the potential to transform transfusion medicine (TM). This survey explored the scope of AI and big data use in TM across the Eastern Mediterranean and North Africa region.

MATERIALS AND

METHODS

A survey was distributed among transfusion professionals to explore current use, perceived benefits and barriers to adopting AI and big data.

RESULTS

Fifty respondents participated; the majority worked in national/regional transfusion services, and 58% worked in academic institutions. Only 24% reported using AI in daily TM practice, primarily for administrative tasks, education and research. Clinical applications were mainly in blood donor recruitment and management. Most used generative AI tools (92%) and were self-taught. Big data were employed in 36% of respondents' institutions, most often for inventory forecasting and optimizing blood product utilization. Most institutions used data based on laboratory information systems (89%), donor databases (72%) and electronic healthcare/patient records (67%). The main challenges and concerns regarding AI adoption were the lack of regulatory guidance, limited expertise, insufficient clinical validation of AI tools, implementation cost and ethical and privacy concerns. In terms of big data, the key barriers were insufficient expertise in data management and a lack of infrastructure for data storage.

CONCLUSION

AI and big data adoption in TM within the region remains limited. Major barriers include regulatory gaps, lack of expertise, cost constraints and infrastructure limitations. Strategic investment in regulatory frameworks, targeted training and technical resources is essential to facilitate safe and effective integration into transfusion practice.